Women's Health

Women's health: a focus on law, regulation and the market

Women's Health is emerging as one of the most dynamic segments of the healthcare market. New regulatory requirements, technological innovations and rising investment are driving the women’s health market forward in equal measure. This creates new market opportunities for companies, investors and healthcare providers, but also presents complex legal and regulatory challenges.

Women's health: from reproductive health to FemTech

The spectrum of women’s health is broad and multifaceted. It encompasses topics ranging from reproductive health to the peri- and post-menopausal periods, oncological indications, as well as medical devices and digital health applications (DiGA). At the same time, investor interest is growing in FemTech companies, fertility clinics and specialised business divisions of major pharmaceutical and MedTech companies.

Legal and regulatory issues in women's health

From a legal perspective, the focus is on, among other things, gender-specific clinical trial requirements in the development of medicinal products, reimbursement issues, the regulation of medical devices and DiGA, data protection, IP strategies and the law governing the advertising of medicinal products. At the same time, M&A transactions in the women’s health market are becoming increasingly significant.

Through our CMS Legal Update series "Women's Health", we shed light on the legal, regulatory and economic developments in this dynamic market. The series offers practical guidance to companies, investors and healthcare providers, and supports informed decision-making in a market that continues to grow in importance.